Average Co-Inventor Count = 3.22
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Medical Diagnostic Laboratories, LLC (11 from 75 patents)
11 patents:
1. RE49026 - Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
2. 10416172 - Recombinant soluble truncated IL-23 receptor (IL-23R) capable of inhibiting IL-23R-mediated cell signaling
3. 9868776 - Anti-sense oligonucleotides targeted against exon 9 of IL-23R-alpha gene and method of using same to induce exon skipping and to treat inflammatory bowel diseases
4. 9605027 - Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
5. 9523073 - Elisa for a naturally-occurring soluble truncated form of IL-23 receptor
6. 9187750 - Anti-sense oligonucleotides targeted against exon 9 of IL-23Rα gene and method of using same to induce exon skipping and to treat inflammatory bowel diseases
7. 9169292 - Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
8. 8946150 - Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
9. 8618070 - Anti-sense oligonucleotides targeted against exon 9 of IL-23Rα gene and method of using same to induce exon skipping and to treat inflammatory bowel diseases
10. 8404824 - Splice variants of human IL-23 receptor (IL-23R) mRNA and use of a Δ9 isoform in predicting inflammatory bowel diseases
11. 8206925 - Splice variants of human IL-23 receptor (IL-23R) mRNA and use of a delta 9 isoform in predicting inflammatory bowel diseases